Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 41,761 shares at $50.25 ($2.1M) on 2022-04-05, disclosed to the SEC on 2022-04-06.
Open-market sale of $2.1M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 128 | $6K | 0.3% |
| 2 | $50.00 | 899 | $45K | 2.1% |
| 3 | $50.25 | 2,538 | $128K | 6.1% |
| 4 | $50.25 | 2,538 | $128K | 6.1% |
| 5 | $50.25 | 17,829 | $896K | 42.7% |
| 6 | $50.25 | 17,829 |
| $896K |
| 42.7% |
| Total | $50.24 avg | 41,761 | $2.1M | 100% |
| Filing → |
| HRMY | SELL | 2022-12-01 | $11.4M | — | Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |